Advertisement

Topics

Companies Related to "Crohn Disease Pipeline Review 2015" [Most Relevant Company Matches] RSS

20:53 EST 20th February 2019 | BioPortfolio

Here are the most relevant search results for "Crohn Disease Pipeline Review 2015" found in our extensive corporate database of over 50,000 company records.

Showing "Crohn Disease Pipeline Review 2015" Companies 1–25 of 3,700+

Extremely Relevant

Crohns & Colitis Foundation of America

Crohn's disease, a chronic inflammatory disease of the gastrointestinal tract, affects approximately 500,000 Americans, including approximately 100,000 pediatric patients. The cause of Crohn's disease is not known, but the disease is associated with an abnormality of the immune system that could be triggered by viral or bacterial infections, a genetic predisposition or diet. Symptoms of Crohn's ...


Crohn'sAdvocate Program

Developed as a support and advocacy program for the half a million Americans affected by Crohn's disease, the Crohn'sAdvocate(TM) program was launched nearly a year ago by UCB. The program takes a 360 degree approach to connecting people with Crohn's disease with experts and Advocates; educating those affected by the condition and empowering the community to take an active part in managing their ...

Relevant

RMEI Medical Education (RMEI) and Crohn's & Colitis Foundation

The Crohn's & Colitis Foundation (the Foundation) is the largest non-profit, voluntary, health organization dedicated to finding cures for inflammatory bowel diseases (IBD). The Foundation’s mission is to cure Crohn's disease and ulcerative colitis, and to improve the quality of life of children and adults who suffer from these diseases. The Foundatio...


Landos Biopharma, Inc.

Landos Biopharma, Inc. is an emerging biopharmaceutical company focused on the discovery and development of first-in-class oral therapeutics for patients with autoimmune diseases. Landos’ lead clinical asset, BT-11, is a novel, locally-acting small molecule targeting inflammatory bowel disease (IBD) that is expected to enter clinical testing for Crohn’s...

Crohn's & Colitis Foundation of America

The Crohn's & Colitis Foundation of America is the largest non-profit, volunteer-driven organization dedicated to finding a cure for Crohn's disease and ulcerative colitis, and it ranks third among leading health non-profits in the percentage of expense devoted to research toward a cure, with approximately 79 cents of every dollar the Foundation spends going to mission-critical programs. The organ...

SLA Pharma AG

S.L.A. Pharma AG is a privately owned Swiss company pioneering the development of speciality pharmaceutical products for gastrointestinal and rare disorders. Their pipeline consists of Phase II and Phase III developments for indications with unmet clinical needs such as anal fissure, symptoms of Crohn’s disease, opioid induced constipation, familial a...

Expert Opinion

The Expert Opinion series of review journals provides systematic and authoritative analysis to support every stage in the pharmaceutical pipeline. Our expertly crafted review articles enable the R&D community to access and track the key advances that lead to the creation of new drugs.

Informa Healthcare - Expert Opinion series

The Expert Opinion series of review journals provides systematic and authoritative analysis to support every stage in the pharmaceutical pipeline. Our expertly crafted review articles enable the R&D community to access and track the key advances that lead to the creation of new drugs

Novogen

Novogen's business is in the most pressing area facing medicine in the modern era - that of degenerative diseases and disorders. Cancer Heart disease (stroke, hypertension, coronary artery disease) Osteoporosis Rheumatoid arthritis Inflammatory Bowel Disease (ulcerative colitis, Crohn's Disease) Neurological diseases (Parkinson's Disease, motor neurone disease) Autoimmune diseases (m...

Alpha Review Corporation

Alpha Review Corporation (ARC) was formed in 1995 as a medical bill review company. ARC customizes its bill review services to meet the client's individual needs by setting specific and unique customer notification parameters, providing customized management reports, and meeting any number of perhaps seemingly minor, but critical needs. This ensures a smoo...

Harvard Business Review

Harvard Business Review is the leading destination for smart management thinking. Through its flagship magazine, 12 international licensed editions, books from Harvard Business Review Press, and digital content and tools published on HBR.org, Harvard Business Review provides professionals around the world with rigorous insights and best practic...

Immune Pharmaceuticals Inc.

Immune Pharmaceuticals Inc. (NASDAQ:IMNP) is dedicated to alleviating the burden of patients suffering from autoimmune diseases by developing novel immunotherapeutic agents. Immune's lead product candidate, bertilimumab, is in Phase 2 clinical development for bullous pemphigoid, an orphan autoimmune dermatological condition, and for ulcerative colitis. Oth...

Technology Review

Technology Review, Inc., an independent media company owned by MIT, is the authority on the future of technology, identifying emerging technologies and analyzing their impact for leaders. Technology Review’s media properties include Technology Review magazine, the oldest technology magazine in the world (founded in 1899); the daily news website Techno...

Technology Review, Inc.

Technology Review, Inc., an independent media company owned by MIT, is the authority on the future of technology, identifying emerging technologies and analyzing their impact for leaders. Technology Review’s media properties include Technology Review magazine, the oldest technology magazine in the world (founded in 1899); the daily news website Techno...

ImproveCareNow

ImproveCareNow is a not-for-profit alliance of health care providers (including physicians, researchers, nurses, quality improvement experts, statisticians, data processing experts and administrators), patients and families all dedicated to helping children and adolescents with Crohn's disease and ulcerative colitis.

PureTech Health

PureTech Health (PureTech Health plc, PRTC.L) is a cross-disciplinary healthcare company, developing innovative products that could improve the lives of billions of patients. PureTech has a pipeline of 12 operating companies, seven of which are "growth stage" with external validation including strategic partnerships, outside funding, proof-of-concep...

Lung Therapeutics, Inc.

Lung Therapeutics, Inc. is a pharmaceutical company formed to leverage 25 years of leading research in lung injury and disease by pursuing niche, orphan drug indications for which there is no current effective therapeutic option. Current pipeline programs include LTI-01 Pleural Effusion (PE) with Loculation, LTI-02 Acute Lung Injury (ALI) and LTI-03 Idiopa...

The Crohn's & Colitis Foundation of America

MDReview

MDReview provides highly effective and innovative physician peer review, delivered with the utmost integrity. MDReview’s main purpose is to support hospitals in making some of the most important decisions that are at the heart of their quality management efforts. With a national reach to a diverse client base in all 50 state, MDReview is the standard ...

Neuraltus Pharmaceuticals

Neuraltus Pharmaceuticals, Inc. is a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet needs, primarily in the treatment of neurodegenerative diseases. Neuraltus has three clinical-stage programs in its development pipeline, including potential treatments for Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's...

Advarra

Advarra, headquartered in Columbia, MD, provides institutional review board (IRB), institutional biosafety committee (IBC) and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers and investigators. Its robust regulatory expertise and innovative technology ensure the highest standards of research ...

Affinivax, Inc.

Affinivax is advancing a next generation vaccine technology platform to enable the development of vaccines that provide the highest level of protection against challenging infectious diseases. Backed by an investment from the Bill & Melinda Gates Foundation, and working with world experts in vaccine discovery and development, Affinivax is focused on creati...

EPIXMedical Incorporated

EPIX's goal is to transform the management and diagnosis of vascular disease through the development of targeted MRI contrast agents. Based on its core, proprietary technology, EPIX is advancing its pipeline of products such as MS-325, the Company's lead MRI contrast agent currently in Phase III trials. MS-325 is also in development to help diagnose coronary artery disease, breast cancer, female s...

Chesapeake IRB

Chesapeake IRB, an AAHRPP-accredited company, provides independent IRB submission and review services to pharmaceutical, biotech and medical device companies, as well as academic medical centers and hospital systems. Its paperless, cloud-based submission and review platform, CIRBI, leads the field and has set the standard in review turnaround time, quality...

Proximagen Neuroscience plc

Proximagen Neuroscience plc is a publicly traded neuroscience research company focused on drug development for neurodegenerative disorders, including Parkinson's disease and Alzheimer's disease. Proximagen is building a compound pipeline to address the significant unmet medical needs of patients with neurodegenerative disease through its own discovery programme for novel, low risk therapeutic can...


More From BioPortfolio on "Crohn Disease Pipeline Review 2015"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks